title: Benefit-risk assessment of acne therapies.
authors.forename: N
authors.initials: N
authors.lastname: Bénéton
authors.forename: H
authors.initials: H
authors.lastname: Bocquet
authors.forename: A
authors.initials: A
authors.lastname: Cosnes
authors.forename: J
authors.initials: J
authors.lastname: Revuz
authors.forename: J C
authors.initials: JC
authors.lastname: Roujeau
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D044383:Black People; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced; D006801:Humans; D008911:Minocycline / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D012306:Risk; D018570:Risk Assessment
chemical_list: D000900:Anti-Bacterial Agents; D008911:Minocycline